uniQure NV Hits Day Low of $14.71 Amid Price Pressure

uniQure NV, a small-cap player in the Pharmaceuticals & Biotechnology sector, experienced significant volatility on September 15, 2025, with its stock price declining by 10.01%. The stock reached an intraday low of USD 14.71, reflecting a challenging trading day.
In terms of performance metrics, uniQure NV's one-day performance was notably poor, down 12.22%, contrasting sharply with the S&P 500's slight decline of 0.05%. Over the past week, the stock has decreased by 2.14%, while it has shown a robust increase of 15.99% over the past month. However, year-to-date, the stock has faced a decline of 16.0%, significantly underperforming the S&P 500, which has gained 11.95% during the same period.

The company's financial health is under scrutiny, with operating losses and a weak ability to service its debt, indicated by a negative EBIT to interest ratio of -1.19. Recent quarterly results revealed a sharp decline in net sales, falling by 52.71% to USD 5.26 million. Despite a remarkable one-year return of 175.74%, the stock's long-term outlook appears challenging, as reflected in its historical performance metrics.